Condition
Gastroenteropancreatic NEC (GEP NEC) clinical trials and research
As of November 12, 2026, Find a Trial lists 2 Gastroenteropancreatic NEC (GEP NEC) clinical trials that are recruiting, in United States. By phase: Phase 1/2 (1), Phase 1 (1). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 2Clinical trials
- 1Country
All recruiting trials (2)
-
First-in-human ML261 CAR T therapy for relapsed/refractory SCLC and select neuroendocrine cancers
This early-phase study tests whether a patient’s own ML261 CAR T cells can be safely given to see if they help people with relapsed or refractory SCLC or certain neuroendocrine cancers.
-
DLL3-targeted alpha radiotherapy ([212Pb]Pb-MP0712) for advanced small cell lung cancer and DLL3-positive neuroendocrine tumors
This will test a DLL3-targeted radioactive drug ([212Pb]Pb-MP0712) to see if it's safe and can shrink tumors in adults with advanced small cell lung cancer or other DLL3-positive neuroendocrine cancers.
Related topics
Quick answers
How many Gastroenteropancreatic NEC (GEP NEC) clinical trials are recruiting right now?
2, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
All of them have sites in United States. Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 1/2: 1, Phase 1: 1. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.